Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. (SHA:603707)
China · Delayed Price · Currency is CNY 9.67
+0.39 (4.20%)
Feb 3, 2026, 3:00 PM CST
SHA:603707 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 649.83 | 826.14 | -189.45 | 1,091 | 1,059 | 806.12 |
Depreciation & Amortization | 174.85 | 174.85 | 154.06 | 139.53 | 93.22 | 84.55 |
Other Amortization | 0.19 | 0.19 | 0.19 | 0.19 | 0.2 | 0.23 |
Loss (Gain) From Sale of Assets | 0.04 | 0.04 | 0.04 | 0.11 | 1.03 | 0.22 |
Asset Writedown & Restructuring Costs | 8.64 | 8.64 | 0.03 | 10.22 | 7.23 | 52 |
Loss (Gain) From Sale of Investments | -7.81 | -7.81 | 85.58 | -24.1 | -24.57 | -10.55 |
Provision & Write-off of Bad Debts | 8.22 | 8.22 | -3.05 | -0.42 | 3.22 | - |
Other Operating Activities | -13.27 | -34.84 | 1,241 | -99.43 | 87.47 | 55.67 |
Change in Accounts Receivable | -13.19 | -13.19 | 163.36 | -1,456 | -148.2 | -345.27 |
Change in Inventory | 598.72 | 598.72 | 213.28 | -731.57 | -444.05 | -1,223 |
Change in Accounts Payable | -185.77 | -185.77 | 224.66 | 1,710 | 46.82 | 11.23 |
Change in Other Net Operating Assets | -20.08 | -20.08 | -21.25 | -15.1 | 13.45 | 11.51 |
Operating Cash Flow | 1,346 | 1,501 | 1,619 | 595.45 | 683.63 | -565.85 |
Operating Cash Flow Growth | -10.42% | -7.28% | 171.92% | -12.90% | - | - |
Capital Expenditures | -453.29 | -506.82 | -419.07 | -470.08 | -440.76 | -294.36 |
Sale of Property, Plant & Equipment | 0 | 0 | 0.15 | 0.11 | 0.54 | 0.12 |
Cash Acquisitions | - | - | - | - | -13.87 | - |
Investment in Securities | 1,139 | -459.05 | -757.47 | 36.06 | 610.72 | -887.57 |
Other Investing Activities | 104.79 | 55.14 | 14.34 | 33.42 | 13.51 | 9.03 |
Investing Cash Flow | 790.49 | -910.73 | -1,162 | -400.5 | 170.14 | -1,173 |
Short-Term Debt Issued | - | - | - | - | - | 3,073 |
Long-Term Debt Issued | - | 1,866 | 3,399 | 3,358 | 2,126 | 1,266 |
Total Debt Issued | 474.85 | 1,866 | 3,399 | 3,358 | 2,126 | 4,339 |
Short-Term Debt Repaid | - | - | - | - | - | -2,311 |
Long-Term Debt Repaid | - | -2,373 | -3,094 | -3,441 | -2,687 | - |
Total Debt Repaid | -1,583 | -2,373 | -3,094 | -3,441 | -2,687 | -2,311 |
Net Debt Issued (Repaid) | -1,108 | -506.04 | 305.39 | -83.41 | -560.94 | 2,028 |
Issuance of Common Stock | - | - | - | 0.37 | 41.17 | 227.35 |
Repurchase of Common Stock | -12.04 | -12.04 | -5.72 | -1.13 | -0.87 | -1.04 |
Common Dividends Paid | -206.65 | -213.19 | -248.47 | -226.65 | -191.75 | -261.21 |
Other Financing Activities | -108.06 | - | - | - | -200 | -19.57 |
Financing Cash Flow | -1,435 | -731.28 | 51.2 | -310.81 | -912.39 | 1,973 |
Foreign Exchange Rate Adjustments | -13.03 | -16.7 | 83.18 | -16.11 | 20.05 | -9.88 |
Net Cash Flow | 689.03 | -157.49 | 591.51 | -131.97 | -38.57 | 224.78 |
Free Cash Flow | 893.18 | 994.41 | 1,200 | 125.37 | 242.87 | -860.21 |
Free Cash Flow Growth | 4.70% | -17.14% | 857.27% | -48.38% | - | - |
Free Cash Flow Margin | 23.75% | 25.34% | 30.53% | 3.38% | 6.59% | -29.51% |
Free Cash Flow Per Share | 0.55 | 0.60 | 0.76 | 0.08 | 0.15 | -0.54 |
Cash Income Tax Paid | - | 104.54 | 108.86 | 91.01 | 46.06 | -5.82 |
Levered Free Cash Flow | 566.1 | 498.14 | 1,279 | -540.91 | -186.72 | -1,220 |
Unlevered Free Cash Flow | 602.71 | 545.43 | 1,330 | -504.75 | -129.08 | -1,184 |
Change in Working Capital | 525.78 | 525.78 | 330.47 | -521.49 | -543.45 | -1,554 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.